A 2010 overview observed inadequate evidence that NSP stops transmission with the hepatitis C virus, tentative evidence that it prevents transmission of HIV and ample evidence that it decreases self-documented injecting chance conduct. Neil Hunt's posting entitled "An evaluation of your evidence-base for harm reduction methods to drug use" examines http://adfoc.us/x71199318